[{"abstract": "William C. Weldon will step down as chief executive of Johnson & Johnson, which has struggled to emerge from a swarm of product recalls and manufacturing lapses.", "web_url": "https://www.nytimes.com/2012/02/22/business/j-j-chief-to-resign-one-role.html", "snippet": "William C. Weldon will step down as chief executive of Johnson & Johnson, which has struggled to emerge from a swarm of product recalls and manufacturing lapses.", "lead_paragraph": "William C. Weldon, who presided over Johnson & Johnson during one of the most tumultuous periods in its history, will step down as chief executive in April, the company announced Tuesday.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/02/22/business/drug/drug-jumbo.jpg", "height": 1024, "width": 658, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2012/02/22/business/drug/drug-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2012/02/22/business/drug/drug-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "J.& J. Chief to Resign One Role", "kicker": null, "content_kicker": null, "print_headline": "J.& J. Chief To Resign One Role", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Recalls and Bans of Products", "rank": 1, "major": "N"}, {"name": "subject", "value": "Suspensions, Dismissals and Resignations", "rank": 2, "major": "N"}, {"name": "persons", "value": "Weldon, William C", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 4, "major": "N"}], "pub_date": "2012-02-22T01:33:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas and Reed Abelson", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}, {"firstname": "Reed", "middlename": null, "lastname": "Abelson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 2}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/6864a750-c561-523a-aa3a-526531d5d9d0", "word_count": 827, "uri": "nyt://article/6864a750-c561-523a-aa3a-526531d5d9d0"}, {"abstract": "Before recalling an all-metal artificial hip, Johnson & Johnson insisted it was safe and maintained that company-sponsored studies refuted complaints that the device was flawed.", "web_url": "https://www.nytimes.com/2012/02/22/business/flawed-depuy-hip-implant-had-early-fda-notice.html", "snippet": "Before recalling an all-metal artificial hip, Johnson & Johnson insisted it was safe and maintained that company-sponsored studies refuted complaints that the device was flawed.", "lead_paragraph": "A year before recalling an artificial hip, an executive at Johnson & Johnson reported in an internal e-mail that the Food and Drug Administration had refused to approve the device, after reviewing company studies that showed it had failed prematurely in \u201csignificant\u201d numbers, requiring repeat surgeries for patients.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/02/22/business/hip/hip-jumbo.jpg", "height": 710, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2012/02/22/business/hip/hip-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2012/02/22/business/hip/hip-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}], "headline": {"main": "Hip Maker Discussed Failures", "kicker": null, "content_kicker": null, "print_headline": "Hip Maker Discussed Failures", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Implants", "rank": 1, "major": "N"}, {"name": "subject", "value": "Medical Devices", "rank": 2, "major": "N"}, {"name": "subject", "value": "Hips", "rank": 3, "major": "N"}, {"name": "organizations", "value": "DePuy Orthopaedics", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 5, "major": "N"}, {"name": "subject", "value": "Recalls and Bans of Products", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 7, "major": "N"}], "pub_date": "2012-02-22T02:00:19+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Barry Meier", "person": [{"firstname": "Barry", "middlename": null, "lastname": "Meier", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/b3370318-f5f7-526a-ad85-75c769495b6f", "word_count": 1045, "uri": "nyt://article/b3370318-f5f7-526a-ad85-75c769495b6f"}, {"abstract": "The text of an internal corporate e-mail on the F.D.A.\u2019s decision not to approve a hip device made by a Johnson & Johnson subsidiary, and a company statement on Tuesday in response to questions.", "web_url": "https://www.nytimes.com/2012/02/22/business/document-2009-e-mail-on-hip-device.html", "snippet": "The text of an internal corporate e-mail on the F.D.A.\u2019s decision not to approve a hip device made by a Johnson & Johnson subsidiary, and a company statement on Tuesday in response to questions.", "lead_paragraph": "In August 2009, the Food and Drug Administration notified DePuy Orthopaedics, a Johnson & Johnson subsidiary, through a \u201cnon-approvable\u201d letter that it had turned down its application to sell a version of a hip device called the A.S.R. in the United States. On Aug. 21, Pamela Plouhar, vice president for worldwide clinical affairs at DePuy, sent the following e-mail to three company executives \u2014 including David Floyd, then DePuy\u2019s president \u2014 reporting the F.D.A. action and its implications. The disclosures in the e-mail contrast with statements made in recent years by the company, which continued to market the device in Europe (and a related model in the United States) before announcing a recall in 2010. Here is the text of the e-mail, followed by a statement issued by DePuy on Tuesday in response to questions from The New York Times.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Document: 2009 E-Mail on Hip Device", "kicker": null, "content_kicker": null, "print_headline": "Document: 2009 E-Mail on Hip Device", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "DePuy Orthopaedics", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 2, "major": "N"}, {"name": "subject", "value": "Medical Devices", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 4, "major": "N"}, {"name": "subject", "value": "Recalls and Bans of Products", "rank": 5, "major": "N"}], "pub_date": "2012-02-22T02:00:28+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "", "person": [], "organization": null}, "type_of_material": "Text", "_id": "nyt://article/e48a298e-8a76-524d-9e08-c3021edbf74d", "word_count": 994, "uri": "nyt://article/e48a298e-8a76-524d-9e08-c3021edbf74d"}, {"abstract": "Johnson & Johnson has submitted concessions to the European Union in an effort to complete its $21.3 billion takeover of the Swiss-American medical tools maker Synthes.", "web_url": "https://dealbook.nytimes.com/2012/02/22/j-j-offers-concessions-to-win-approval-for-synthes-deal/", "snippet": "Johnson & Johnson has submitted concessions to the European Union in an effort to complete its $21.3 billion takeover of the Swiss-American medical tools maker Synthes.", "lead_paragraph": "LONDON \u2014 Johnson & Johnson has submitted concessions to the European Union in an effort to complete its $21.3 billion takeover of the Swiss-American medical tools maker Synthes.", "source": "The New York Times", "multimedia": [], "headline": {"main": "J.&J. Offers Concessions to Win Approval for Synthes Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "European Union", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Synthes Inc", "rank": 4, "major": "N"}], "pub_date": "2012-02-22T16:34:57+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Mark Scott", "person": [{"firstname": "Mark", "middlename": null, "lastname": "Scott", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d6182995-cdd2-570a-8ccf-17bd54790e64", "word_count": 268, "uri": "nyt://article/d6182995-cdd2-570a-8ccf-17bd54790e64"}]